| Course | HLTH 4320 Nutrition Across the Lifespan |
|---|---|
| Week | Week 2 |
| Paper type | Guideline read |
| Length | About 1,050 words, 6 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | BS in Public Health |
| Updated | October 2026 |
Free sample paper for HLTH 4320 Week 2
Reading the Calcium and Vitamin D Reference Intakes at the Source: What the 2011 Committee Decided, What It Declined to Decide and How Later Trials Tested Its Caution
Student Name
Walden University
HLTH 4320: Nutrition Across the Lifespan
Instructor Name
Month Day, Year
Reading the Calcium and Vitamin D Reference Intakes at the Source: What the 2011 Committee Decided, What It Declined to Decide and How Later Trials Tested Its Caution
Why Read the Document Itself
Calcium and vitamin D are among the most discussed nutrients in popular health writing, and much of that writing describes the official guidance secondhand. Secondhand accounts often report the numbers and drop the reasoning: which outcome the numbers were built on, what the committee concluded about other outcomes and how much confidence it placed in each. This paper reads the guidance at its source, the Institute of Medicine's 2011 reference intake report on these two nutrients, together with the summary its committee published for clinicians (Institute of Medicine, 2011; Ross et al., 2011). It then sets the committee's most cautious conclusions beside two large trials published afterward.
What the Committee Was Asked to Do
The committee's task was to review the evidence and set reference values, the Estimated Average Requirement, the Recommended Dietary Allowance, the Adequate Intake where needed and the Tolerable Upper Intake Level, for calcium and vitamin D across the life stages of healthy people in the United States and Canada. The task was to define requirements for a population, not to recommend treatment for individuals with disease. That boundary is easy to lose in secondhand accounts, which often present the values as if they were clinical targets for patients with low vitamin D levels.
The Decision About Which Outcome to Use
The most consequential decision in the report was the choice of indicator: the health outcome on which requirements would be based. The committee reviewed evidence on bone health and on a long list of other outcomes, including cancer, cardiovascular disease, diabetes and autoimmune disorders. It concluded that the evidence supported a key role for calcium and vitamin D in skeletal health, consistent with cause and effect, and that this provided a sound basis for setting requirements. For the other outcomes, it found the evidence "inconsistent, inconclusive as to causality, and insufficient to inform nutritional requirements," and randomized trial evidence for them "limited and generally uninformative" (Ross et al., 2011, p. 53).
This is the passage most often lost in retelling. The values are built on bone. The report did not conclude that vitamin D has no effect on cancer or heart disease; it concluded that the evidence at the time could not support setting requirements on those outcomes.
The Values and How They Were Built
Two features of how the vitamin D values were built deserve attention. First, they were set assuming minimal sun exposure. Because vitamin D made in the skin varies widely with latitude, season, skin pigmentation and behavior, and because sun exposure carries a risk of skin cancer, the committee chose not to count on it. The values therefore cover people who get little sun. Second, the committee tied the RDA to a serum 25-hydroxyvitamin D level of at least 20 ng/mL, a level it judged sufficient for bone health in nearly everyone. Many laboratories at the time used 30 ng/mL as the lower limit of normal, which made far more people appear deficient.
Table 1
Selected Reference Values From the 2011 Report
| Nutrient and group | RDA | Basis | |
|---|---|---|
| Calcium, life stages from age 1 | 700 to 1,300 mg per day, varying by age and sex | Bone health | |
| Vitamin D, ages 1 to 70 | 600 IU per day | Bone health; serum 25-hydroxyvitamin D of at least 20 ng/mL | |
| Vitamin D, ages 71 and older | 800 IU per day | Bone health; same serum level | |
Values as reported by the committee's summary (Ross et al., 2011); each RDA should satisfy all but a small fraction of its group.
What the Committee Warned About
The report includes warnings that secondhand accounts rarely carry. The committee observed that higher serum levels were not consistently associated with greater benefit and that some outcomes showed U-shaped associations, with risk rising at both low and high levels. It judged that published estimates had counted too many North Americans as short of vitamin D, and it called for reassessment of laboratory reference ranges to avoid both undertreatment and overtreatment (Ross et al., 2011). Read at the source, the report is as much a caution against excess as a recommendation for adequacy.
How Later Trials Tested the Caution
The committee's judgment that evidence for outcomes beyond bone was insufficient was tested by VITAL, a large randomized trial in which 25,871 U.S. adults were assigned to 2,000 IU of vitamin D3 daily or placebo. Across roughly five years of follow-up, vitamin D did not lower the incidence of invasive cancer (hazard ratio 0.96) or major cardiovascular events (hazard ratio 0.97) compared with placebo (Manson et al., 2019). A later analysis of the same trial found no significant effect on total, nonvertebral or hip fractures among generally healthy midlife and older adults who were not selected for deficiency (LeBoff et al., 2022).
These results do not contradict the 2011 values, which were built for adequacy, not for supplementation of people already getting enough. They are consistent with the committee's caution: doses well above the RDA, given to a population not selected for low levels, did not produce the benefits that had been widely predicted.
What Reading the Source Changes
A secondhand account might say, "Experts recommend 600 IU of vitamin D for bone, heart and immune health." Read at the source, the guidance says something narrower and more useful: 600 IU meets the bone-health needs of nearly all people aged 1 to 70 with little sun exposure; evidence for other outcomes was insufficient to set requirements; and higher intakes and serum levels were not shown to add benefit. The difference matters for anyone deciding whether a supplement or a laboratory test is needed.
Conclusion
The 2011 calcium and vitamin D report built its values on bone health, set them for people with minimal sun exposure, tied them to a serum level of 20 ng/mL and warned that inadequacy had been overestimated. It declined to base requirements on cancer, heart disease or other outcomes. Large trials published later found that high-dose vitamin D supplementation did not reduce cancer, cardiovascular events or fractures in generally healthy adults, which fits the caution the committee wrote into the document itself.
References
Institute of Medicine. (2011). Dietary Reference Intakes for calcium and vitamin D (A. C. Ross, C. L. Taylor, A. L. Yaktine, & H. B. Del Valle, Eds.). The National Academies Press. https://doi.org/10.17226/13050
LeBoff, M. S., Chou, S. H., Ratliff, K. A., Cook, N. R., Khurana, B., Kim, E., Cawthon, P. M., Bauer, D. C., Black, D., Gallagher, J. C., Lee, I.-M., Buring, J. E., & Manson, J. E. (2022). Supplemental vitamin D and incident fractures in midlife and older adults. New England Journal of Medicine, 387(4), 299-309. https://doi.org/10.1056/NEJMoa2202106
Manson, J. E., Cook, N. R., Lee, I.-M., Christen, W., Bassuk, S. S., Mora, S., Gibson, H., Gordon, D., Copeland, T., D'Agostino, D., Friedenberg, G., Ridge, C., Bubes, V., Giovannucci, E. L., Willett, W. C., & Buring, J. E. (2019). Vitamin D supplements and prevention of cancer and cardiovascular disease. New England Journal of Medicine, 380(1), 33-44. https://doi.org/10.1056/NEJMoa1809944
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., Kovacs, C. S., Mayne, S. T., Rosen, C. J., & Shapses, S. A. (2011). The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: What clinicians need to know. The Journal of Clinical Endocrinology & Metabolism, 96(1), 53-58. https://doi.org/10.1210/jc.2010-2704
Reading the HLTH 4320 Week 2 instructions
This assignment wants a reading of one federal or National Academies guidance document at its source, not a summary of a summary. Pick the document your section assigns or one approved by your instructor and give its full citation. Explain what the authors were asked to do and the population their values cover. Report the main recommendations accurately, with numbers and units, and say what evidence each one rests on. Then identify what the document leaves out on purpose, such as outcomes it judged unsupported, and quote the wording where it matters. Many prompts add a final step: compare the guidance with research published since. Aim for an APA paper of four to five pages with a title page and headings. Avoid health blogs and fact sheets as main sources, since they are the secondhand accounts the exercise is meant to correct.
How the HLTH 4320 Week 2 example is put together
Seven headed sections carry the paper. The opening explains why secondhand accounts of calcium and vitamin D drop the reasoning behind the numbers. Next comes the committee's charge, framed as setting population requirements rather than treating disease. The longest section covers the indicator decision and quotes, with a page number, the committee's finding that non-skeletal evidence was inconsistent. Table 1 lists calcium allowances by age, the two vitamin D allowances and the bone basis for each. A section on warnings summarizes the concern over inflated deficiency estimates and laboratory cutoffs of 30 ng/mL. VITAL's 25,871 participants and its hazard ratios of 0.96 for cancer and 0.97 for cardiovascular events follow, with the later fracture result. The closing pages set a typical secondhand sentence beside what the report actually says, then restate the committee's choices in four clauses.
HLTH 4320 Week 2 rubric: what earns full marks
Instructors grade a guideline read on fidelity to the document. Reporting values with the wrong units or the wrong age band costs heavily, and so does presenting population requirements as clinical treatment goals. Strong papers locate the reasoning behind the numbers, here the indicator chosen and the assumption of minimal sun exposure, because that is the content a summary loses. A direct quotation with a page number earns credit under evidence, provided it is short and explained. Comparison with later research is often a separate row: it should test the document's own claims, not just add more facts. Organization counts for clear headings that follow the document's logic. APA formatting covers the edited National Academies report, a journal summary and two trial articles, each matched to an in-text citation. Work that never leaves the abstract falls into the lower bands.
Common HLTH 4320 Week 2 mistakes, and how to avoid them
Students often lose points by treating the vitamin D allowance as advice for people with low blood levels, when the report set values for healthy populations. Another frequent error is listing the committee's numbers without the 20 ng/mL serum level that anchors them. Some papers present VITAL as proof that the 2011 values were wrong; the trial tested a much higher dose in people who were mostly not deficient, so it supports the committee's caution rather than overturning it. Check that each table value comes from the committee's own summary. Keep quotations short and give the page. Before you submit, read your conclusion aloud and ask whether it says something narrower than the popular claim; if it does not, it has slipped back into a secondhand account. A custom read of a different guidance document, such as the 2019 sodium and potassium report, can be requested through the form.
Get a HLTH 4320 Week 2 example written to your instructions
Forward the assignment prompt and the rubric your classroom posted, and a written sample built on the same document comes back inside 24-48h. The first custom sample is free. What arrives is reference material. It is not turned in, and the desk claims no part of the paper that carries your name.
More HLTH 4320 papers and BS in Public Health samples
- HLTH 4320 Week 1: Dietary Reference Intakes Post
- HLTH 4320 Week 3: Pregnancy and Infancy Brief
- HLTH 4320 Week 4: Childhood Requirements Table
- HLTH 4320 Week 5: Sugary Drinks Evidence Appraisal
- HLTH 4320 Week 6: Nutrition Label Analysis
- HLTH 4320 Week 7: Breakfast Claim Discussion Post
- HLTH 4320 Week 8: Adult Fiber Population Brief
- HLTH 4320 Week 9: Older Adult Nutrition Brief
- HLTH 4320 Week 10: Infant Iron Education Handout
- HLTH 4320 Week 11: Iron Across the Lifespan Paper
- HLTH 4300 Week 2: Self-Report Critique
- HLTH 4200 Week 2: Surveillance Note
- HLTH 3115 Week 2: Measurement Exercise
- HLTH 2500 Week 2: Theory Summary
HLTH 4320 Week 2 questions, answered
Where can I find a free HLTH 4320 Week 2 sample paper?
The full guideline read on the 2011 calcium and vitamin D report, including Table 1, the VITAL comparison and four APA references, is posted here without a paywall.
Why does the HLTH 4320 Week 2 example focus on bone health?
The 2011 committee built every calcium and vitamin D value on skeletal outcomes because only that evidence was consistent with cause and effect, and the paper explains the decision.
What serum level are the vitamin D allowances tied to?
The committee linked its allowances to a 25-hydroxyvitamin D level of at least 20 ng/mL, lower than the 30 ng/mL that many laboratories then treated as the edge of normal.
Did the VITAL trial contradict the 2011 report?
No. VITAL gave 2,000 IU a day to adults who were mostly not deficient and found no drop in cancer, cardiovascular events or fractures, which fits the committee's caution about excess.
Can a fact sheet replace the original report as the main source?
Fact sheets are secondhand accounts, so the sample cites the National Academies report and the committee's published summary directly and uses no fact sheet as evidence.